Literature DB >> 2916514

Effects of theophylline on behavior and learning in children with asthma.

L Rappaport1, H Coffman, R Guare, T Fenton, C DeGraw, F Twarog.   

Abstract

This study examined the potential side effects of theophylline on behavior, attention, memory, and fine motor function in children with asthma. Seventeen children of normal intelligence who were intermittent theophylline users were recruited. Each was not taking medication at the initiation of the study. During the study, each child took the study medication (Theo-Dur tablets, 14 to 16 mg/kg per day or their usual dose, whichever was higher, or placebo) divided every 12 hours for 3 1/2 days (seven doses). A double-blind crossover design was employed such that each subject was randomly assigned to a group receiving theophylline/placebo or placebo/theophylline. After the first period, subjects were tested on a neuropsychological battery designed to assess cognitive performance, while the children, parents, and teachers filled out questionnaires concerning behavior and attention. The same procedure was repeated two weeks later (period 2) under the opposite drug condition. Data were analyzed by means of an analysis of variance, with time (period 1 vs period 2 [performance]) as a repeated measure and medication group as a between-subjects factor. Dependent variables consisted of 27 measures of performance, behavior, and attention. Only one of the 27 analyses revealed a significant group by time interaction. This analysis suggested a significant improvement in memory while taking theophylline; however, a different form of the same test showed no effect. Children and parents also completed a side-effects scale under both drug conditions. When the children were taking theophylline, parents and children noted that the children had more stomachaches and children noted more "shaking hands." The following observations suggest that the failure to find significant behavioral side effects while taking theophylline is not due to the relatively small sample size: (1) Almost all of the analyses fell far short of statistical significance, with findings indicating no trends toward poor performance while taking medication. (2) Correlations between the theophylline level and change in performance clustered around zero, with positive and negative values occurring with about equal frequency. (3) Neither parents nor children could accurately guess the child's medication condition. Thus, although there have been numerous reports on the behavioral side effects of theophylline, such reactions were not revealed in this study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916514     DOI: 10.1001/archpedi.1989.02150150126032

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  12 in total

1.  Impulsivity among adolescents with ADHD and bronchial asthma.

Authors:  Uzi Brook; Mona Boaz
Journal:  Indian J Pediatr       Date:  2005-11       Impact factor: 1.967

Review 2.  Oral xanthines as maintenance treatment for asthma in children.

Authors:  P Seddon; A Bara; F M Ducharme; T J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

3.  A comparison of the CNS effects of enprofylline and theophylline in healthy subjects assessed by performance testing and subjective measures.

Authors:  B Tiplady; D Fagan; M Lamont; M Brockway; D B Scott
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 4.  Adverse reactions and interactions with theophylline.

Authors:  M H Skinner
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

5.  Knowledge of and reported asthma management among South Australian general practitioners.

Authors:  J R Coates; I D Steven; J Beilby; G Coffey; J C Litt; C Wagner
Journal:  Br J Gen Pract       Date:  1994-03       Impact factor: 5.386

6.  Effect of aminophylline on brain tissue oxygenation in patients with chronic obstructive lung disease.

Authors:  G J Addis
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

7.  Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance.

Authors:  M F Fitzpatrick; H Engleman; K F Whyte; I J Deary; C M Shapiro; N J Douglas
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

8.  Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.

Authors:  M F Fitzpatrick; T Mackay; H Driver; N J Douglas
Journal:  BMJ       Date:  1990-12-15

Review 9.  Neuropsychological dysfunction in asthmatic children.

Authors:  R D Annett; B G Bender
Journal:  Neuropsychol Rev       Date:  1994-06       Impact factor: 7.444

10.  Determination of theophylline clearance in South African children.

Authors:  J H Botha; I Tyrannes; R Miller; A Wesley
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.